Falcon (Edison Scientific) deep research report: rat Ugt2a1 (UDP-glucuronosyltransferase 2A1, UGT-olf)
-
Ugt2a1/UGT2A1 is the olfactory UDP-glucuronosyltransferase (UGT-olf), a UGT2A subfamily member enriched in neuro-olfactory tissues, confirming gene identity (UniProt P36510).
"historically termed **UGT-olf/UGTolf**, a member of the UGT2A subfamily enriched in neuro‑olfactory tissues"
-
UGT2A1 catalyzes glucuronidation, transferring glucuronic acid from UDP-glucuronic acid to nucleophilic acceptors to form more hydrophilic glucuronides, supporting the glucuronosyltransferase molecular function.
"UGT2A1 is a **phase II xenobiotic‑metabolizing enzyme** that catalyzes **glucuronidation**: transfer of glucuronic acid from **UDP‑glucuronic acid (UDPGA)** to small molecules bearing suitable nucleophilic groups (e.g., hydroxyl groups), producing **more hydrophilic glucuronides** that tend to be eliminated more readily."
-
Glucuronidation by UGT2A1 is part of the olfactory perireceptor process and can contribute to odorant signal termination, supporting the sensory-perception annotations.
"In the olfactory system, such glucuronidation is part of the **perireceptor process**, i.e., local metabolism in the mucus/epithelium that shapes the concentration-time profile of odorants reaching olfactory receptors and can thereby contribute to **signal termination**"
-
Glucuronidated odorant metabolites fail to stimulate canonical cAMP signaling in olfactory cilia preparations, mechanistically linking UGT2A1 activity to reduced receptor activation.
"olfactory cilia preparations show that **glucuronidated odorant metabolites fail to stimulate canonical cAMP signaling**, consistent with a mechanism by which glucuronidation reduces receptor activation and promotes signal termination"
-
Immunogold EM localizes UGT2A1 to the plasma membrane of olfactory cilia (in addition to sustentacular-cell ER), supporting membrane localization proximal to odorant receptors.
"Critically, immunogold EM supports localization of UGT2A1 at the **plasma membrane of olfactory cilia**—a location that is unusually proximal to odorant receptors and supports rapid metabolism in the perireceptor space"
-
UGT2A1 immunolocalizes broadly in the apical olfactory epithelium including sustentacular cells and Bowman's glands/ducts.
"localize UGT2A1 broadly within the olfactory epithelium and especially in the apical region, including **sustentacular cells** and **Bowman’s glands/ducts**"
-
Ex vivo electroolfactogram experiments show topical β-glucuronidase selectively increases the eugenol but not amyl-acetate response, giving causal in-situ evidence that glucuronidation modulates the olfactory response.
"counteracting UGT activity with topical **β‑glucuronidase** increased the EOG response amplitude to **eugenol** but not to **amyl acetate**, consistent with the interpretation that glucuronidation reduces effective eugenol concentration at receptors"
-
UGT2A1 substrate scope extends beyond odorants to coumarins, drugs/xenobiotics and steroids (estradiol/testosterone), supporting broader xenobiotic and steroid handling.
"monoterpenoid alcohols** (e.g., geraniol, linalool, borneol, menthol), **coumarins** (e.g., umbelliferone derivatives), **drugs/xenobiotics** (e.g., ibuprofen, valproic acid), and **steroids** (e.g., estradiol/testosterone), supporting a role that extends beyond “odorant-only” metabolism and into broader nasal detoxification and local steroid handling"
-
Nasal UGTs including UGT2A1 form a protective metabolic barrier reducing local toxicity and xenobiotic delivery to the brain, supporting the xenobiotic metabolic process role.
"frames nasal UGTs (including UGT2A1 expressed in olfactory epithelium) as part of a protective barrier that can reduce local toxicity and potentially limit delivery of xenobiotics to the brain via the nasal route"
-
Human UGT2A1 is reported highly active in bile-acid glucuronidation, corroborating the bile acid metabolic process annotation as a non-core detoxification role.
"UGT2A1 is described as **highly active in bile-acid glucuronidation**, and it notes characterization of UGT2A1 variants and disease connections (human context)"